James R. Gruber Eton Pharmaceuticals, Inc. (ETON) insider trading activity

ETON Quotes by TradingView

James R. Gruber is Chief Financial Officer of Eton Pharmaceuticals, Inc.. Currently has a direct ownership of 213,420 shares of ETON, which is worth approximately $3.61 Million. The most recent transaction as insider was on Jan 14, 2026, when has been sold 2,293 shares (Common Stock) at a price of $15.47 per share, resulting in proceeds of $35,472. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 213K
4.23% 3M change
n/a 12M change
Total Value Held $3.61 Million

James R. Gruber Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 14 2026
SELL
Payment of exercise price or tax liability
$35,472 $15.47 p/Share
2,293 Reduced 1.06%
213,420 Common Stock
Dec 12 2025
SELL
Payment of exercise price or tax liability
$77,168 $16.99 p/Share
4,542 Reduced 2.06%
215,713 Common Stock
Aug 20 2025
SELL
Open market or private sale
$42,148 $16.02 p/Share
2,631 Reduced 1.27%
204,753 Common Stock
Aug 19 2025
SELL
Open market or private sale
$631,565 $16.16 p/Share
39,082 Reduced 15.99%
205,299 Common Stock
JRG

James R. Gruber

Chief Financial Officer
Deerpark, IL

Track Institutional and Insider Activities on ETON

Follow Eton Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETON shares.

Notify only if

Insider Trading

Get notified when an Eton Pharmaceuticals, Inc. insider buys or sells ETON shares.

Notify only if

News

Receive news related to Eton Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ETON